Risk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era

Second malignancies remain an issue affecting morbidity and mortality in long-term survivors of early stage Hodgkin's lymphoma (HL). We undertook this study to determine if treatment in the modern era resulted in decreased second malignancies. Patients diagnosed with stage I–II cHL between 1988...

Descripción completa

Detalles Bibliográficos
Autores principales: LeMieux, Melissa H, Solanki, Abhishek A, Mahmood, Usama, Chmura, Steven J, Koshy, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402065/
https://www.ncbi.nlm.nih.gov/pubmed/25620577
http://dx.doi.org/10.1002/cam4.405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402065/
https://www.ncbi.nlm.nih.gov/pubmed/25620577
http://dx.doi.org/10.1002/cam4.405

Ejemplares similares